⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
March 16, 2026 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against VTGN
globenewswire.com
VTGN
Bronstein, Gewirtz & Grossman LLC Urges Vistagen Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
VTGN
Pomerantz LLP Informs Shareholders of Class Action Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
VTGN
Pomerantz LLP Notifies Investors of Class Action Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
Pomerantz LLP Notifies Investors of Class Action Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
VTGN SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026
accessnewswire.com
VTGN
VTGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Vistagen Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
VTGN
Pomerantz LLP Issues Reminder to Shareholders in Vistagen Therapeutics, Inc. of Class Action Lawsuit – VTGN
accessnewswire.com
VTGN
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PomDoctor and Vistagen and Encourages Investors to Contact the Firm
globenewswire.com
VTGN
POM